Home › Pancreatic Cancer › California › Fullerton
Pancreatic Cancer clinical trials in Fullerton, CA
4 studies for Pancreatic Cancer are looking for participants at sites in and around Fullerton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RecruitingPhase 3
- Investigative Site US085, Fullerton
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RecruitingPhase 3
- Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton, Fullerton
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recruiting
- St Jude Heritage Medical Group, Fullerton
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
RecruitingPhase 2/3
- Providence Medical Foundation, Fullerton
About Pancreatic Cancer
The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.
More about Pancreatic Cancer on MedlinePlus
Pancreatic Cancer trials in other cities
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- Durham, NC24 studies
Other studies in Fullerton
- Non-Small Cell Lung Cancer13 studies
- Breast Cancer9 studies
- Ovarian Cancer6 studies
- Lupus5 studies
- Cancer (all types)5 studies
- Lung Cancer4 studies
- Stomach Cancer3 studies
- Esophageal Cancer3 studies
- Melanoma3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Schizophrenia3 studies
- Colorectal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.